NO963572L - Inhibin-sammensetninger og fremgangsmåter for bruk av disse - Google Patents
Inhibin-sammensetninger og fremgangsmåter for bruk av disseInfo
- Publication number
- NO963572L NO963572L NO963572A NO963572A NO963572L NO 963572 L NO963572 L NO 963572L NO 963572 A NO963572 A NO 963572A NO 963572 A NO963572 A NO 963572A NO 963572 L NO963572 L NO 963572L
- Authority
- NO
- Norway
- Prior art keywords
- protein
- heterologous protein
- inhibin
- heterologous
- fused
- Prior art date
Links
- 239000000893 inhibin Substances 0.000 title abstract 5
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 abstract 10
- 108090000623 proteins and genes Proteins 0.000 abstract 10
- 102000014914 Carrier Proteins Human genes 0.000 abstract 4
- 108010078791 Carrier Proteins Proteins 0.000 abstract 4
- 241001465754 Metazoa Species 0.000 abstract 3
- 241000271566 Aves Species 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 abstract 1
- 101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 abstract 1
- 241000287530 Psittaciformes Species 0.000 abstract 1
- 229940098773 bovine serum albumin Drugs 0.000 abstract 1
- 239000002299 complementary DNA Substances 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Endocrinology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Confectionery (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Non-Alcoholic Beverages (AREA)
- General Preparation And Processing Of Foods (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Dental Preparations (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20296494A | 1994-02-28 | 1994-02-28 | |
| PCT/US1995/002795 WO1995022980A1 (fr) | 1994-02-28 | 1995-02-28 | Compositions a base d'inhibine et applications |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO963572D0 NO963572D0 (no) | 1996-08-27 |
| NO963572L true NO963572L (no) | 1996-10-25 |
Family
ID=22751927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO963572A NO963572L (no) | 1994-02-28 | 1996-08-27 | Inhibin-sammensetninger og fremgangsmåter for bruk av disse |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0804219B1 (fr) |
| JP (1) | JPH09510702A (fr) |
| CN (1) | CN1149258A (fr) |
| AT (1) | ATE220554T1 (fr) |
| AU (1) | AU704737B2 (fr) |
| BR (1) | BR9507426A (fr) |
| CA (1) | CA2184183C (fr) |
| DE (1) | DE69527439T2 (fr) |
| DK (1) | DK0804219T3 (fr) |
| ES (1) | ES2181771T3 (fr) |
| FI (1) | FI963325A (fr) |
| MX (1) | MX9603702A (fr) |
| NO (1) | NO963572L (fr) |
| NZ (1) | NZ282981A (fr) |
| PL (1) | PL184202B1 (fr) |
| PT (1) | PT804219E (fr) |
| RU (1) | RU2170100C2 (fr) |
| WO (1) | WO1995022980A1 (fr) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5786179A (en) * | 1994-02-28 | 1998-07-28 | Agritech Technologies Ltd. | Heterologous protein comprising avian alpha-subunit inhibin protein and methods of producing same |
| US5725858A (en) * | 1994-02-28 | 1998-03-10 | Agritech Technologies, Ltd. | Methods of enhancing production performance of birds comprising administration of heterologous protein comprising avian alpha-subunit inhibin protein |
| MXPA05004849A (es) * | 2002-11-07 | 2006-03-08 | Agritech Technology Ltd | Novedosas composiciones de multiples peptidos antigenicos relacionados con inhibina, que mejoran el desempeno de produccion avicola. |
| PL3308788T3 (pl) | 2005-06-23 | 2019-05-31 | Biogen Ma Inc | Kompozycje i sposoby modulacji splicingu smn2 |
| AU2006285850A1 (en) | 2005-08-29 | 2007-03-08 | Japan Science And Technology Agency | Antibody produced using ostrich and method for production thereof |
| KR20120093138A (ko) | 2009-06-17 | 2012-08-22 | 콜드스프링하버러보러토리 | 대상에게서 ｓｍｎ２ 스플라이싱을 조정하기 위한 조성물 및 방법 |
| US9926559B2 (en) | 2013-01-09 | 2018-03-27 | Biogen Ma Inc. | Compositions and methods for modulation of SMN2 splicing in a subject |
| BR102014005376A2 (pt) * | 2014-03-07 | 2016-02-10 | Ouro Fino Saúde Animal Ltda | antígeno de inibina alfa, gene codificante de inibina alfa, gene codificante de proteína de fusão, processo de obtenção do antígeno de inibina alfa, composição antigênica, uso do antígeno de inibina alfa e uso da composição antigênica |
| WO2015161170A2 (fr) | 2014-04-17 | 2015-10-22 | Isis Pharmaceuticals, Inc. | Compositions et procédés de modulation de l'épissage du smn2 chez un patient |
| BR112017004056A2 (pt) | 2014-09-12 | 2017-12-05 | Biogen Ma Inc | composições e métodos para detecção da proteína smn em um indivíduo e tratamento de um indivíduo |
| US11198867B2 (en) | 2016-06-16 | 2021-12-14 | Ionis Pharmaceuticals, Inc. | Combinations for the modulation of SMN expression |
| CN110551744A (zh) * | 2019-09-18 | 2019-12-10 | 普健生物（武汉）科技有限公司 | 一种人抑制素a的核苷酸序列及重组表达人抑制素a的方法 |
| AU2021225957A1 (en) | 2020-02-28 | 2022-09-08 | Ionis Pharmaceuticals, Inc. | Compounds and methods for modulating SMN2 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5089396A (en) * | 1985-10-03 | 1992-02-18 | Genentech, Inc. | Nucleic acid encoding β chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid |
| US4864019A (en) * | 1985-11-08 | 1989-09-05 | The Salk Institute For Biological Studies | Antibodies to inhibin and conjugates produced therefrom |
-
1995
- 1995-02-28 AT AT95913576T patent/ATE220554T1/de not_active IP Right Cessation
- 1995-02-28 DE DE69527439T patent/DE69527439T2/de not_active Expired - Fee Related
- 1995-02-28 RU RU96119774/13A patent/RU2170100C2/ru not_active IP Right Cessation
- 1995-02-28 NZ NZ282981A patent/NZ282981A/en unknown
- 1995-02-28 AU AU20959/95A patent/AU704737B2/en not_active Ceased
- 1995-02-28 PL PL95316628A patent/PL184202B1/pl not_active IP Right Cessation
- 1995-02-28 BR BR9507426A patent/BR9507426A/pt not_active IP Right Cessation
- 1995-02-28 MX MX9603702A patent/MX9603702A/es not_active IP Right Cessation
- 1995-02-28 EP EP95913576A patent/EP0804219B1/fr not_active Expired - Lifetime
- 1995-02-28 CN CN95192317A patent/CN1149258A/zh active Pending
- 1995-02-28 DK DK95913576T patent/DK0804219T3/da active
- 1995-02-28 CA CA002184183A patent/CA2184183C/fr not_active Expired - Fee Related
- 1995-02-28 ES ES95913576T patent/ES2181771T3/es not_active Expired - Lifetime
- 1995-02-28 PT PT95913576T patent/PT804219E/pt unknown
- 1995-02-28 JP JP7522532A patent/JPH09510702A/ja not_active Withdrawn
- 1995-02-28 WO PCT/US1995/002795 patent/WO1995022980A1/fr active IP Right Grant
-
1996
- 1996-08-27 NO NO963572A patent/NO963572L/no unknown
- 1996-08-27 FI FI963325A patent/FI963325A/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL316628A1 (en) | 1997-02-03 |
| EP0804219A4 (fr) | 1999-02-24 |
| EP0804219B1 (fr) | 2002-07-17 |
| CA2184183C (fr) | 2005-02-08 |
| AU2095995A (en) | 1995-09-11 |
| WO1995022980A1 (fr) | 1995-08-31 |
| DE69527439T2 (de) | 2003-02-20 |
| CA2184183A1 (fr) | 1995-08-31 |
| JPH09510702A (ja) | 1997-10-28 |
| CN1149258A (zh) | 1997-05-07 |
| ES2181771T3 (es) | 2003-03-01 |
| FI963325A (fi) | 1996-10-21 |
| DK0804219T3 (da) | 2002-11-11 |
| NZ282981A (en) | 1998-08-26 |
| PT804219E (pt) | 2002-12-31 |
| FI963325A0 (fi) | 1996-08-27 |
| NO963572D0 (no) | 1996-08-27 |
| EP0804219A1 (fr) | 1997-11-05 |
| AU704737B2 (en) | 1999-05-06 |
| RU2170100C2 (ru) | 2001-07-10 |
| MX9603702A (es) | 1997-12-31 |
| DE69527439D1 (de) | 2002-08-22 |
| PL184202B1 (pl) | 2002-09-30 |
| BR9507426A (pt) | 1997-09-16 |
| ATE220554T1 (de) | 2002-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Price et al. | Matrix Gla protein, a new γ-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone | |
| NO963572D0 (no) | Inhibin-sammensetninger og fremgangsmåter for bruk av disse | |
| Solari et al. | Biosynthesis of the IgA antibody receptor: a model for the transepithelial sorting of a membrane glycoprotein | |
| CA2290485A1 (fr) | Procede de production de proteines non immunogenes | |
| ATE262348T1 (de) | Mittel zur verabreichung von antigenen | |
| IT1203672B (it) | Proteina ibrida comprendente frammenti proteici collegati da legami peptidici e relativo gene di fusione composizione contenente tale proteina | |
| KR900700116A (ko) | 뼈-유도 단백질 | |
| ATE235250T1 (de) | Inhibinzusammensetzungen und verfahren zur erhöhung der reproduzierenden leistung | |
| ES2113088T3 (es) | Metodo de entrega de agentes a celulas diana. | |
| DE69637914D1 (de) | Impstoff gegen den für atemwegs- und reproduktionserkrankungen beim schwein verantwortlichen virus | |
| ATE214942T1 (de) | Fibrinogen-bildungsprotein | |
| BR9809656A (pt) | Composição imunopotencializante | |
| Bal et al. | Formation of the extracellular mucous matrix of olfactory neuroepithelium: identification of partially glycosylated and nonglycosylated precursors of olfactomedin | |
| EP0973934A4 (fr) | Proteines non secretees produites de maniere transgenique | |
| PL330794A1 (en) | Polypeptides capable of forming structures bonding an antigen exhibiting antigenic specificity in respect to antigenes rh d, dna sequences coding such polypeptides and method of producing and using them | |
| ATE141283T1 (de) | Verfahren zur reinigung eines hochglykosylierten proteins | |
| Cencič et al. | The porcine trophoblastic interferon‐γ, secreted by a polarized epithelium, has specific structural and biochemical properties | |
| AU7526196A (en) | Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands | |
| Yakulis et al. | Production of Fe fragments of IgM | |
| ATE465751T1 (de) | Verfahren zur vorbeugung und linderung angiogener erkrankungen durch impfung mit dem rezeptor für gbs-toxin (cm101) | |
| AU633967B2 (en) | Cleavage promoter | |
| Pierre et al. | Mouse secretory component | |
| Pass et al. | Generation of antibodies to the urokinase receptor (uPAR) by DNA immunization of uPAR knockout mice: Membrane‐bound uPAR is not required for an antibody response | |
| Mezzano et al. | ANTIBODY-PRODUCTION AND ANTIGENIC SPECIFIC SUPPRESSION TO BOVINE SERUM-ALBUMIN IN UREMIC RATS | |
| Trenkle et al. | Studies on pituitary lactogenic hormone. XXI. Immunochemical studies of the sheep hormone |